logo

Contact information

Dr. med. Sebastian Scheich

Department of Medicine II

University Hospital Frankfurt

Goethe University Frankfurt

Theodor-Stern-Kai 7

60590 Frankfurt/Main

CV

Academic education

2009 - 2015 Studies in medicine (Staatsexamen),  Justus-Liebig-University, Giessen, Germany

Scientific degrees

2016 Dr. med., Laboratory for Experimental Trauma Surgery (supervisor: Prof. Dr. K. Lips), University Hospital Giessen, Germany

 

Scientific career

2025 - present Attending Physician, University Hospital Frankfurt, Department of Hematology and Oncology, Germany
2023 - present  Junior Group Leader, University Hospital Frankfurt, Department of Hematology and Oncology; Frankfurt Cancer Institute, Germany
2025 Board certification internal medicine
2023 - 2025  Resident Physician, University Hospital Frankfurt, Department of Hematology and Oncology, Germany
2019 - 2023 Postdoc, National Institutes of Health, National Cancer Institute, Lymphoid Malignancies Branch (Advisor: Louis M. Staudt M.D., Ph.D.), USA
2017 - 2019 Postdoc, University Hospital Frankfurt, Department of Hematology and Oncology (Supervisor: Prof. Dr. Thomas Oellerich), Germany
2015 - 2019 Resident Physician, University Hospital Frankfurt, Department of Hematology and Oncology, Germany

 

Honors/ Awards/ Memberships

2023 - present Faculty Member LOEWE Center “Frankfurt Cancer Institute”
2023 GLA research award lymphoma biology, German Lymphoma Alliance (GLA)
2021 - 2023 NIH/NCI research fellowship, National Cancer Institute, NIH, Bethesda USA
2019 - 2021 DFG-Fellowship, German Research Association 

Publications

  • Response to Bruton’s tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy

    Diffuse large B cell lymphoma (DLBCL) is an aggressive, profoundly heterogeneous cancer, presenting a challenge for precision medicine. Bruton’s tyrosine kinase (BTK) inhibitors block B cell receptor (BCR) signaling and are particularly effective in certain molecular subtypes of DLBCL that rely on…